Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
Journal of Perinatal Medicine|October 26, 2023
The impact of the COVID-19 pandemic on antenatal care provision and associated mental health, obstetric and neonatal outcomesAnousha Woods, Emma Ballard, Sailesh Kumar, et al.Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|January 14, 2016
Can you really swim? Validation of self and parental reports of swim skill with an inwater swim test among children attending community pools in Washington StateMelissa C Mercado, Linda Quan, Elizabeth Bennett, et al.Allergy and Asthma Proceedings|April 22, 2015
EpiPen4Schools pilot survey: Occurrence of anaphylaxis, triggers, and epinephrine administration in a U.S. school settingMartha V White, Susan L Hogue, M Elizabeth Bennett, et al.British Journal of Haematology|July 24, 2015
Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II studyPeter M Voorhees, Robert Z Orlowski, Flora Mulkey, et al.Current Problems in Cardiology|November 20, 2024
The enigmatic role of SIRT2 in the cardiovascular system: Deciphering its protective and detrimental actions to unlock new avenues for therapeutic interventionAbdulaziz Hassan Alhasaniah, Mohammed Alissa, Fahmy Gad Elsaid, et al.BMJ Open|August 16, 2022
Lifetime prevalence and correlates of perinatal depression in a case-cohort study of depressionJacqueline Kiewa, Samantha Meltzer-Brody, Jeannette Milgrom, et al.Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Decision Considerations and Strategies for Lip Surgery in Patients with Cleft lip/Palate: A Qualitative StudyCarroll Ann Trotman, Julian Faraway, M Elizabeth Bennett, et al.Journal of Dermatology and Dermatitis|June 26, 2024
Decision Considerations and Strategies for Lip Surgery in Patients with Cleft lip/Palate: A Qualitative StudyCarroll Ann Trotman, Julian Faraway, M Elizabeth Bennett, et al.Lancet (London, England)|September 23, 2021
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trialEnriqueta Felip, Nasser Altorki, Caicun Zhou, et al.Journal for Immunotherapy of Cancer|October 30, 2023
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trialCaicun Zhou, Minu K Srivastava, Hao Xu, et al.Pageof 7